AI & Biotech Surge
Investors Track Sub-$2 Stocks as AI, Biotech, and Digital Infrastructure Drive Growth and Strategic Moves
Anonymous
Key Points
1
Mentari Therapeutics’ financing milestone: private placement of $200 million has brought total committed financing to about $490 million ahead of the merger, underscoring continued investor interest in next‑generation biotech platforms.
2
Peraso’s 60GHz millimeter-wave wireless technology is being positioned for secure, high-capacity, low-latency communications across military drones, robotics, industrial automation, and AI-driven infrastructure.
3
Sphere 3D is evaluating roughly 53 MW of power‑ready infrastructure for AI, HPC, GPU infrastructure, and cloud computing deployments, and is expanding its government affairs reach within the Tennessee Valley Authority region.
4
A broad slate of tech and biotech names under $1 are drawing investor attention amid catalysts in AI, biopharma, defense tech, media, and digital infrastructure, including INM, PRSO, CHAI, TOON, LICN, and KUST.
A cluster of small-cap stocks trading under $2 is drawing fresh investor attention, driven by breakthroughs in artificial intelligence, biotech, and defense technology. Mentari Therapeutics alone locked in a $200 million private placement, pushing its total committed financing to roughly $490 million ahead of a major merger, according to Financial Content.
The wave of activity spans companies working on drone communications, AI home renovation tools, and antimicrobial drug candidates. Analysts and retail investors alike are watching tickers like INM, PRSO, CHAI, TOON, LICN, and KUST for near-term catalysts, Financial Content reported.
Mentari's $490 Million War Chest Fuels Biotech Merger
Mentari Therapeutics closed a $200 million private placement, a financing round where shares are sold directly to select investors rather than on the open market. That deal pushed its total committed funding to about $490 million, according to Financial Content. The money is earmarked to support a merger pipeline centered on next-generation migraine therapy. InMed Pharmaceuticals, trading under the ticker INM, has drawn attention in connection with Mentari's moves.
The milestone signals that institutional money is still flowing into small-cap biopharma despite broader market caution. Migraine treatments represent a growing market, with tens of millions of Americans affected. A well-funded merger pipeline gives Mentari a clearer path to clinical trials and, eventually, commercialization.
Peraso's 60GHz Tech Targets Drones and Military Robots
Peraso Technologies, trading as PRSO, is pushing its 60GHz millimeter-wave wireless technology into defense and industrial markets. The tech delivers secure, high-capacity, low-latency communications — meaning fast data with almost no delay — for military drones, robots, and AI-driven factory systems, according to KBEW 98 Country.
Millimeter-wave radio signals can carry far more data than standard Wi-Fi while staying harder to intercept. That makes Peraso's chips attractive for defense contractors who need reliable links between autonomous systems. The global military drone market is expanding fast, giving Peraso a potentially large customer base for its niche hardware.
Sphere 3D Evaluates 53 MW of AI Power, Plans Rebrand to DarkHorse
Sphere 3D is evaluating roughly 53 megawatts of power-ready infrastructure for AI computing, high-performance computing, and cloud deployments, according to My Eagle Country. The company also signed a 30 MW partnership with Bitdeer, a major crypto and computing firm. On top of that, Sphere 3D is expanding its government affairs reach inside the Tennessee Valley Authority region.
The company plans to rebrand as DarkHorse, a name change that signals a fresh strategic identity focused on AI infrastructure. Rebrands often accompany pivots in business model. Here, Sphere 3D appears to be moving away from its legacy tech roots and fully into the AI data center race, where power availability is now the key bottleneck.
HomeGPT and LABT Round Out the AI and Biotech Watch List
Core AI Holdings is promoting HomeGPT, a tool that lets homeowners visualize renovations before breaking ground. The product reflects rising demand for vertical AI apps — software built for one specific job rather than general use. Financial Content noted that CHAI is part of a broader slate of sub-$1 names attracting speculative interest tied to the AI boom.
On the biotech side, Lakewood-Amedex, ticker LABT, released data supporting its Nu-3 drug candidate against antimicrobial resistance — bacteria that no longer respond to standard antibiotics. That is a growing global health crisis, which gives LABT's early-stage data real-world urgency. KBEW 98 Country listed LABT among the top under-$2 names to monitor for near-term news flow.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
12
Articles
30
Reach
42
Topics
A
AnonymousAuthor